Because sensing through the RLR pathway culminates in NF-κB and type I IFN signalings (important for tumor cell survival or inflammation in the tumor microenviroment), we further investigated a possible role of ADAR1-mediated RNA editing in the activation of this pathway. Here, ADAR is linked to neoplasm.